Use of maintenance rituximab (R) in the United States following R-based induction for follicular lymphoma (FL). 18F-fluorodeoxglucose (FDG) positron emission tomography (PET) versus FLIPI as a ...
Therapeutic outcome in prognostic subgroups of de-novo acute myeloid leukemia (AML) and the role of the age factor. A study in 1834 patients of 16 to 84 years No significant financial relationships to ...
Please provide your email address to receive an email when new articles are posted on . Lymphopenia at diagnosis or during follow-up can predict OS among patients with multiple myeloma. Researchers ...
Please provide your email address to receive an email when new articles are posted on . Results showed two regimens — 120 mg/kg cyclophosphamide and 125 mg/m 2 fludarabine, or 60 mg/kg ...
Severe lymphopenia, an adverse treatment effect associated with chemotherapy, radiotherapy, and immunotherapy, significantly lowers overall survival in non-small cell lung cancer and multiple types of ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. A low lymphocyte count in people presenting to the hospital with COVID-19 could help physicians ...
Progressive multifocal leukoencephalopathy (PML) occurring with ocrelizumab (Ocrevus) monotherapy developed in a 78-year-old man with progressive multiple sclerosis (MS), the first such case known, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback